Efficacy and Safety of tirofiban in acute ischemic stroke patients with early neurological deterioration: a meta-analysis
Abstract Background Patients with acute ischemic stroke (AIS) who experience early neurological deterioration (END) often face significant neurological disability. Given the limited efficacy of current oral antiplatelet regimens in this period, tirofiban has emerged as a potential therapeutic candid...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2026-03-01
|
| Serija: | BMC Neurology |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s12883-026-04849-x |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
